From Lab to Launchpad: How ASU Engineers Are Transforming Health Innovation Into Startups

Arizona State University’s commitment to innovation isn’t just about research discoveries – it’s about turning ideas into real‑world impact. Across ASU’s engineering and health ecosystems, faculty members are transforming their lab breakthroughs into startups that could shape the future of medicine.

In the School of Biological and Health Systems Engineering within the Ira A. Fulton Schools of Engineering, researchers are bridging the gap between academic science and clinical application by founding companies that tackle unmet medical needs. Supported by ASU’s entrepreneurial infrastructure and funding from national partners like the National Institutes of Health, these ventures demonstrate how university research can become life‑changing solutions.

Engineering Immune Protection

Associate Professor Jessica Weaver and her team launched ImmunoShield Therapeutics, a startup developing a novel hydrogel platform that protects transplanted therapeutic cells from the immune system’s attack. This technology could make regenerative medicine and treatments for conditions like diabetes safer and more accessible – reducing or eliminating the need for long‑term immunosuppressive drugs.

Weaver credits ASU’s collaborative innovation ecosystem – including Skysong Innovations and the Venture Devils program – with helping her translate fundamental research into a potential clinical product.

Patient‑Centered Medical Technologies

Biomedical engineer Brent Vernon is co‑founder of Sonoran Biosciences, a company focused on designing advanced drug‑delivery hydrogels to improve postoperative pain care. Their goal? Treat pain at the site of injury and reduce reliance on systemic opioid medications – a critical need in today’s healthcare landscape.

Vernon’s entrepreneurial journey began right at ASU, highlighting how engineering education and innovation support help faculty turn research into companies that could change patient outcomes.

Advancing Biomedical Imaging and Diagnostics

Other faculty researchers, such as Associate Professor Shaopeng Wang, partner with established industry players to commercialize advanced biosensing and imaging technologies. These innovations have applications in drug discovery, molecular diagnostics, and fundamental biological research – underscoring that pathways to impact can be as diverse as the technologies themselves.

A Culture of Innovation at ASU

What unites these ventures is more than technology – it’s ASU’s culture that encourages engineers to think like entrepreneurs. From student‑faculty collaborations to access to patent support and startup funding, ASU provides the tools innovators need to see their ideas through from concept to company.

As these biomedical startups continue to grow, they reflect ASU’s larger mission: not only to advance knowledge, but to transform that knowledge into solutions that improve health and quality of life for people everywhere.

Learn more about ASU discoveries that are contributing to changing the world and making America the world’s leading economic power at researchmatters.asu.edu.

Read the full story and learn more here